As of January 2025, Suzhou Zelgen Biopharmaceuticals has a market cap of $2.25B. This makes Suzhou Zelgen Biopharmaceuticals the world's 4697th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $1.60B | -16.79% |
2023 | $1.92B | 26.95% |
2022 | $1.51B | -29.08% |
2021 | $2.13B | -9.10% |
2020 | $2.35B | - |